Clinical Study of Divozilimab in Patients With Systemic Scleroderma

Clinical trial NCT05726630 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05726630
Sponsor: Biocad
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Scleroderma

Start date: 2022-12-26
Primary completion: 2024-10-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.